. 2023 Sep;12(3):None. doi: 10.1016/j.hlpt.2023.100780

Table 4.

Digital health applications supporting the treatment of patients with endocrine, nutritional and metabolic diseases.

DiHA name (manufacturer)	Target group/ function	CE mark^*	2017/745 risk class^*	Data protection^⁎⁎	NICE evidence standards framework classification [15]	Technical interoperability standard	Compatibility with ELGA	Information on used algorithms	Source^⁎⁎⁎
DiabCare	chronically ill; indirect intervention	NR	NR	Yes	C	NR	NR	NR	https://kit.ait.ac.at/wp-content/uploads/2018/06/TGD-Tirol-Steiermark-VAEB_V2.0–2018–03–30_AIT.pdf
DiabMemory 2	chronically ill; indirect intervention	NR	NR	Yes	C	NR	NR	NR	https://kit.ait.ac.at/wp-content/uploads/2018/06/TGD-Tirol-Steiermark-VAEB_V2.0–2018–03–30_AIT.pdf
Freestyle LibreLink – BE (Abbott SA/NV)	chronically ill; complex monitoring	Yes	2b	Yes	C	KMEHR, HL7 CDA, HL7 FHIR, SNOMED-CT	Yes	NR	https://myfreestyle.be/fr/
Guardian Connect App (Medtronic Belgium)	chronically ill; complex monitoring	Yes	2A	No^‡	C	NR	NR	NR	https://guardianconnect.medtronic-diabetes.co.uk/
mySugr Tagebuch-App	chronically ill; indirect intervention	Yes	2A	Yes	C	KMEHR, HL7 CDA, HL7 FHIR, SNOMED-CT	Yes	NR	https://www.mysugr.com/en/diabetes-app/
Vitadio	chronically ill; indirect intervention	Yes	NR	Yes	C	NR	NR	NR	https://vitad.io/
zanadio (aidhere GmbH)	chronically ill; indirect intervention	Yes	NR	Yes	C	HL7 FHIR	No	NR	https://zanadio.de/

^⁎

according to manufacturer website.

^⁎⁎

data protection statement (compliance with the General Data Protection Regulation, including data storage in the EU)

Abbreviations: CE - european conformity (“conformité européenne”); GDPR - general data protection regulation; MDR - medical device regulation; NR - not reported.

^⁎⁎⁎

cited 30.09.2021.

^‡